Genistein ameliorates adverse cardiac effects induced by arsenic trioxide through preventing cardiomyocytes apoptosis

Cellular Physiology and Biochemistry

Volumn 31, Issue 1, 2013, Pages 80-91

  Fan, Yuhua ^a   Wang, Chen ^a   Zhang, Yong ^a   Hang, Pengzhou ^a   Liu, Yan ^a   Pan, Zhenwei ^a   Wang, Ning ^a   Du, Zhimin ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Arsenic trioxide; Genistein; QT interval prolongation

Indexed keywords

ARSENIC TRIOXIDE; CASPASE 3; GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; ELECTROCARDIOGRAPHY; HEART FUNCTION; HEART MUSCLE CELL; HEMODYNAMICS; LONG QT SYNDROME; MITOCHONDRIAL MEMBRANE POTENTIAL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN PHOSPHORYLATION; RAT; WESTERN BLOTTING; CALCIUM CELL LEVEL; DRUG EFFECT; DRUG MECHANISM; ELECTROCARDIOGRAM; MALE; PROTEIN DETERMINATION; QT PROLONGATION;

RATTUS;

EID: 84873037009     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000343351     Document Type: Article

References (43)

1. Cyranoski D: Arsenic patent keeps drug for rare cancer out of reach of many. Nat Med 2007;13:1005.
2. Fox E, Razzouk BI, Widemann BC, Xiao S, O'Brien M, Goodspeed W, Reaman GH, Blaney SM, Murgo AJ, Balis FM, Adamson PC: Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma. Blood 2008;111:566-573.
3. Mathews V, Chendamarai E, George B, Viswabandya A, Srivastava A: Treatment of acute promyelocytic leukemia with single-agent arsenic trioxide. Mediterr J Hematol Infect Dis 2011;3:e2011056.
4. Barbey JT, Pezzullo JC, Soignet SL: Effect of arsenic trioxide on QT interval in patients with advanced malignancies. J Clin Oncol 2003;21:3609-3615.
5. Drolet B, Simard C, Roden DM: Unusual effects of aQT-prolonging drug, arsenic trioxide, on cardiac potassium currents. Circulation 2004;109:26-29.
6. Mumford JL, Wu K, Xia Y, Kwok R, Yang Z, Foster J, Sanders WE Jr: Chronic Arsenic Exposure and Cardiac Repolarization Abnormalities with QT Interval Prolongation in a Population-based Study. Environ Health Perspect 2007;115:690-694.
7. Zhao X, Feng T, Chen H, Shan H, Zhang Y, Lu Y, Yang B: Arsenic trioxide-induced apoptosis in h9c2 cardiomyocytes: Implications in cardiotoxicity. Basic Clin Pharmacol Toxicol 2008;102:419-425.
8. Chen X, Shan H, Zhao J, Hong Y, Bai Y, Sun I, Pan Z, Zhang Y, Yang B, Du Z: L-type calcium current (ica,l) and inward rectifier potassium current (ik1) are involved in qt prolongation induced by arsenic trioxide in rat. Cell Physiol Biochem 2010;26:967-974.
9. Hayakawa Y, Chandra M, Miao W, Shirani J, Brown JH, Dorn GW, 2nd, Armstrong RC, Kitsis RN: Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of galpha(q) transgenic mice. Circulation 2003;108:3036-3041.
10. James TN: Long reflections on the qt interval: The sixth annual gordon k. Moe lecture. J Cardiovasc Electrophysiol 1996;7:738-759.
11. Tfelt-Hansen J, MacLeod RJ, Chattopadhyay N, Yano S, Quinn S, Ren X, Terwilliger EF, Schwarz P, Brown EM: Calcium-sensing receptor stimulates pthrp release by pathways dependent on pkc, p38 mapk, jnk, and erk1/2 in h-500 cells. Am J Physiol Endocrinol Metab 2003;285:E329-337.
12. Kim J, Sharma RP: Calcium-mediated activation of c-jun nh2-terminal kinase (jnk) and apoptosis in response to cadmium in murine macrophages. Toxicol Sci 2004;81:518-527.
13. Kim BJ, Ryu SW, Song BJ: Jnk-and p38 kinase-mediated phosphorylation of bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma hepg2 cells. J Biol Chem 2006;281:21256-21265.
14. Muslin AJ: Mapk signalling in cardiovascular health and disease: Molecular mechanisms and therapeutic targets. Clin Sci (Lond) 2008;115:203-218.
15. Xie P, Guo S, Fan Y, Zhang H, Gu D, Li H: Atrogin-1/mafbx enhances simulated ischemia/reperfusion-induced apoptosis in cardiomyocytes through degradation of mapk phosphatase-1 and sustained jnk activation. J Biol Chem 2009;284:5488-5496.
16. Cao W, Xie YH, Li XQ, Zhang XK, Chen YT, Kang R, Chen X, Miao S, Wang SW: Burn-induced apoptosis of cardiomyocyte is survivin dependent and regulated by pi3k/akt, p38 mapk and erk pathways. Basic Res Cardiol 2011;106:1207-1220.
17. Boulares AH, Yakovlev AG, Ivanova V, Stoica BA, Wang G, Iyer S, Smulson M: Role of poly(adp-ribose) polymerase (parp) cleavage in apoptosis. Caspase 3-resistant parp mutant increases rates of apoptosis in transfected cells. J Biol Chem 1999;274:22932-22940.
18. Valsecchi AE, Franchi S, Panerai AE, Sacerdote P, Trovato AE, Colleoni M: Genistein, a natural phytoestrogen from soy, relieves neuropathic pain following chronic constriction sciatic nerve injury in mice: Anti-inflammatory and antioxidant activity. J Neurochem 2008;107:230-240.
19. Banerjee S, Li Y, Wang Z, Sarkar FH: Multi-targeted therapy of cancer by genistein. Cancer Lett 2008;269:226-242.
20. Si H, Liu D: Phytochemical genistein in the regulation of vascular function: New insights. Curr Med Chem 2007;14:2581-2589.
21. Belevych AE, Warrier S, Harvey RD: Genistein inhibits cardiac l-type Ca2+ channel activity by a tyrosine kinase-independent mechanism. Mol Pharmacol 2002;62:554-565.
22. Ji ES, Yue H, Wu YM, He RR: Effects of phytoestrogen genistein on myocardial ischemia/reperfusion injury and apoptosis in rabbits. Acta Pharmacol Sin 2004;25:306-312.
23. Puddu PE, Jouve R, Mariotti S, Giampaoli S, Lanti M, Reale A, Menotti A: Evaluation of 10 qt prediction formulas in 881 middle-aged men from the seven countries study: Emphasis on the cubic root fridericia's equation. J Electrocardiol 1988;21:219-229.
24. Chu WF, Sun HL, Dong DL, Qiao GF, Yang BF: Increasing intracellular calcium of guinea pig ventricular myocytes induced by platelet activating factor through ip3 pathway. Basic Clin Pharmacol Toxicol 2006;98:104-109.
25. Kubalova Z, Terentyev D, Viatchenko-Karpinski S, Nishijima Y, Gyorke I, Terentyeva R, da Cunha DN, Sridhar A, Feldman DS, Hamlin RL, Carnes CA, Gyorke S: Abnormal intrastore calcium signaling in chronic heart failure. Proc Natl Acad Sci USA 2005;102:14104-14109.
26. Hajnoczky G, Csordas G, Das S, Garcia-Perez C, Saotome M, Sinha Roy S, Yi M: Mitochondrial calcium signalling and cell death: Approaches for assessing the role of mitochondrial Ca2+ uptake in apoptosis. Cell Calcium 2006;40:553-560.
27. Yokoshiki H, Sumii K, Sperelakis N: Inhibition of l-type calcium current in rat ventricular cells by the tyrosine kinase inhibitor, genistein and its inactive analog, daidzein. J Mol Cell Cardiol 1996;28:807-814.
28. Fang J, Song XW, Tian J, Chen HY, Li DF, Wang JF, Ren AJ, Yuan WJ, Lin L: Overexpression of microrna-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes. Apoptosis 2012; 17: 410-423.
29. Zhao XY, Li GY, Liu Y, Chai LM, Chen JX, Zhang Y, Du ZM, Lu YJ, Yang BF: Resveratrol protects against arsenic trioxide-induced adverse cardiotoxicity in vitro and in vivo. Br J Pharmacol 2008;154:105-113.
30. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw BA: Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996;335:1182-1189.
31. Narula J, Hajjar RJ, Dec GW: Apoptosis in the failing heart. Cardiol Clin 1998;16:691-710, ix.
32. Bennett MR: Apoptosis in the cardiovascular system. Heart 2002;87:480-487.
33. James TN, Terasaki F, Pavlovich ER, Vikhert AM: Apoptosis and pleomorphic micromitochondriosis in the sinus nodes surgically excised from five patients with the long qt syndrome. J Lab Clin Med 1993;122:309-323.
34. Yang L, Zou XJ, Gao X, Chen H, Luo JL, Wang ZH, Liang QS, Yang GT: Sodium tanshinone iia sulfonate attenuates angiotensin ii-induced collagen type i expression in cardiac fibroblasts in vitro. Exp Mol Med 2009;41:508-516.
35. Timmins JM, Ozcan L, Seimon TA, Li G, Malagelada C, Backs J, Backs T, Bassel-Duby R, Olson EN, Anderson ME, Tabas I: Calcium/calmodulin-dependent protein kinase ii links er stress with fas and mitochondrial apoptosis pathways. J Clin Invest 2009;119:2925-2941.
36. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of erk and jnk-p38 map kinases on apoptosis. Science 1995;270:1326-1331.
37. Sun HY, Wang NP, Halkos M, Kerendi F, Kin H, Guyton RA, Vinten-Johansen J, Zhao ZQ: Postconditioning attenuates cardiomyocyte apoptosis via inhibition of jnk and p38 mitogen-activated protein kinase signaling pathways. Apoptosis 2006;11:1583-1593.
38. Kim SH, Sharma RP: Mercury-induced apoptosis and necrosis in murine macrophages: Role of calcium-induced reactive oxygen species and p38 mitogen-activated protein kinase signaling. Toxicol Appl Pharmacol 2004;196:47-57.
39. Chen CL, Lin CF, Chang WT, Huang WC, Teng CF, Lin YS: Ceramide induces p38 mapk and jnk activation through a mechanism involving a thioredoxin- interacting protein-mediated pathway. Blood 2008;111:4365-4374.
40. Zhuang S, Demirs JT, Kochevar IE: P38 mitogen-activated protein kinase mediates bid cleavage, mitochondrial dysfunction, and caspase-3 activation during apoptosis induced by singlet oxygen but not by hydrogen peroxide. J Biol Chem 2000;275:25939-25948.
41. Harada J, Sugimoto M: An inhibitor of p38 and jnk map kinases prevents activation of caspase and apoptosis of cultured cerebellar granule neurons. Jpn J Pharmacol 1999;79:369-378.
42. Shimizu H, Banno Y, Sumi N, Naganawa T, Kitajima Y, Nozawa Y: Activation of p38 mitogen-activated protein kinase and caspases in uvb-induced apoptosis of human keratinocyte hacat cells. J Invest Dermatol 1999;112:769-774.
43. Chen Z, Seimiya H, Naito M, Mashima T, Kizaki A, Dan S, Imaizumi M, Ichijo H, Miyazono K, Tsuruo T: Ask1 mediates apoptotic cell death induced by genotoxic stress. Oncogene 1999;18:173-180.